Nucleome featured in New Scientist’s UK Life Science Innovation report



Many diseases are associated with genetic variation within the non-coding genome. These variants regulate gene expression through interactions that cannot be understood from DNA sequence alone. They promise significant insights into human disease, but translating these signals into drug targets remains one of genomics’ hardest challenges. Nucleome believes it has the solution.

Read the full article here

Previous New technology helps decode the genetic changes behind disease New technology helps decode the genetic changes behind disease
October 9, 2026